Quick Answer
Alzamend Neuro, Inc. reported Operating Income of -$4.50 million for fiscal year 2025.
Alzamend Neuro, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$4.50M | +54.7% |
| 2024 | -$9.94M | +33.2% |
| 2023 | -$14.87M | -20.7% |
| 2022 | -$12.32M | -148.8% |
| 2021 | -$4.95M | -11.9% |
| 2020 | -$4.42M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| October 31, 2025 | -$998.1K | +26.5% | +63.0% |
| July 31, 2025 | -$2.70M | -180.6% | -160.3% |
| January 31, 2025 | -$1.04M | +61.0% | +23.6% |
| October 31, 2024 | -$1.36M | +53.2% | -41.1% |
| July 31, 2024 | -$962.4K | +72.7% | +63.8% |
| January 31, 2024 | -$2.66M | +51.0% | +8.3% |
| October 31, 2023 | -$2.90M | +6.6% | +17.7% |
| July 31, 2023 | -$3.53M | -16.2% | +35.0% |
- Alzamend Neuro, Inc. showed an increase of +54.7% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Alzamend Neuro, Inc.’s operating income has declined by 1.6% (from -$4.42 million to -$4.50 million).
- The most recent figure is from Alzamend Neuro, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: